Cite

HARVARD Citation

    Meissner, E. et al. (2016). Simtuzumab treatment of advanced liver fibrosis in HIV and HCV‐infected adults: results of a 6‐month open‐label safety trial. Liver international. pp. 1783-1792. [Online]. 
  
Back to record